BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35604910)

  • 1. Genome-wide gain-of-function screening identifies EZH2 mediating resistance to PI3Kα inhibitors in oesophageal squamous cell carcinoma.
    Xing H; Gao M; Wang Y; Zhang X; Shi J; Wang X; Liu X; Ma Q; Kong X; Yang C; Ding J; Meng L
    Clin Transl Med; 2022 May; 12(5):e835. PubMed ID: 35604910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI3Kα inhibitors sensitize esophageal squamous cell carcinoma to radiation by abrogating survival signals in tumor cells and tumor microenvironment.
    Shi JJ; Xing H; Wang YX; Zhang X; Zhan QM; Geng MY; Ding J; Meng LH
    Cancer Lett; 2019 Sep; 459():145-155. PubMed ID: 31173854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors.
    Zhang X; Wang Y; Zhang X; Shen Y; Yang K; Ma Q; Qiao Y; Shi J; Wang Y; Xu L; Yang B; Ge G; Hu L; Kong X; Yang C; Chen Y; Ding J; Meng L
    Signal Transduct Target Ther; 2023 Apr; 8(1):153. PubMed ID: 37041169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive resistance to PI3Kα-selective inhibitor CYH33 is mediated by genomic and transcriptomic alterations in ESCC cells.
    Wang YX; Zhang X; Ma QY; Hu LD; Zhang X; Wang Y; Xu L; Yang CH; Tan C; Kong XY; Ding J; Meng LH
    Cell Death Dis; 2021 Jan; 12(1):85. PubMed ID: 33446653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2.
    Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y
    Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-30d inhibits the migration and invasion of human esophageal squamous cell carcinoma cells via the post‑transcriptional regulation of enhancer of zeste homolog 2.
    Xie R; Wu SN; Gao CC; Yang XZ; Wang HG; Zhang JL; Yan W; Ma TH
    Oncol Rep; 2017 Mar; 37(3):1682-1690. PubMed ID: 28184915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EZH2 deregulates BMP, Hedgehog, and Hippo cell signaling pathways in esophageal squamous cell carcinoma.
    Ardalan Khales S; Forghanifard MM; Abbaszadegan MR; Hosseini SE
    Adv Med Sci; 2023 Mar; 68(1):21-30. PubMed ID: 36403545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA PSMA3-AS1 promotes malignant phenotypes of esophageal cancer by modulating the miR-101/EZH2 axis as a ceRNA.
    Qiu BQ; Lin XH; Ye XD; Huang W; Pei X; Xiong D; Long X; Zhu SQ; Lu F; Lin K; Zhang XQ; Xu JJ; Sheng LL; Zhang XM; Zhang PF; Wu YB
    Aging (Albany NY); 2020 Jan; 12(2):1843-1856. PubMed ID: 32005028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma.
    Huang SD; Yuan Y; Zhuang CW; Li BL; Gong DJ; Wang SG; Zeng ZY; Cheng HZ
    Mol Cancer; 2012 Aug; 11():51. PubMed ID: 22867052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HERES, a lncRNA that regulates canonical and noncanonical Wnt signaling pathways via interaction with EZH2.
    You BH; Yoon JH; Kang H; Lee EK; Lee SK; Nam JW
    Proc Natl Acad Sci U S A; 2019 Dec; 116(49):24620-24629. PubMed ID: 31732666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repressing MYC by targeting BET synergizes with selective inhibition of PI3Kα against B cell lymphoma.
    Chen ZQ; Cao ZR; Wang Y; Zhang X; Xu L; Wang YX; Chen Y; Yang CH; Ding J; Meng LH
    Cancer Lett; 2022 Jan; 524():206-218. PubMed ID: 34688842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant overexpression of EZH2 and H3K27me3 serves as poor prognostic biomarker for esophageal squamous cell carcinoma patients.
    Liu F; Gu L; Cao Y; Fan X; Zhang F; Sang M
    Biomarkers; 2016; 21(1):80-90. PubMed ID: 26631178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the Correlation of EZH2 and Cancer Stem Cell Markers in Esophageal Squamous Cell Carcinoma.
    Karami Madani G; Rad A; Molavi M; Ardalan Khales S; Abbaszadegan MR; Forghanifard MM
    J Gastrointest Cancer; 2018 Dec; 49(4):437-441. PubMed ID: 28681114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
    Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
    Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
    He LR; Liu MZ; Li BK; Jia WH; Zhang Y; Liao YJ; Chen YC; Zhang LJ; Guan XY; Zeng YX; Kung HF; Xie D
    Int J Cancer; 2010 Jul; 127(1):138-47. PubMed ID: 19904743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer.
    Wang Y; Li X; Liu X; Chen Y; Yang C; Tan C; Wang B; Sun Y; Zhang X; Gao Y; Ding J; Meng L
    Cancer Biol Med; 2019 Feb; 16(1):66-83. PubMed ID: 31119047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA SNHG6 promotes oesophageal squamous cell carcinoma by downregulating the miR-101-3p/EZH2 pathway.
    Zhang Y; Li R; Ding X; He M; Zhang R
    J Biochem Mol Toxicol; 2022 Feb; 36(2):e22959. PubMed ID: 34766670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma.
    Bolidong D; Domoto T; Uehara M; Sabit H; Okumura T; Endo Y; Nakada M; Ninomiya I; Miyashita T; Wong RW; Minamoto T
    Sci Rep; 2020 Jul; 10(1):11807. PubMed ID: 32678196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-101 suppresses tumor proliferation and migration, and induces apoptosis by targeting EZH2 in esophageal cancer cells.
    Lin C; Huang F; Li QZ; Zhang YJ
    Int J Clin Exp Pathol; 2014; 7(10):6543-50. PubMed ID: 25400732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of the long intergenic non-protein coding RNA POU3F3 promote DNA methylation in esophageal squamous cell carcinoma cells.
    Li W; Zheng J; Deng J; You Y; Wu H; Li N; Lu J; Zhou Y
    Gastroenterology; 2014 Jun; 146(7):1714-26.e5. PubMed ID: 24631494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.